Skip to main content

GSK plc

GLAXF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001131399

No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $70.1M in total; no superinvestor holds it.

Other share classesGSK

Key figures

Market capADS ratio not in SEC data
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
2
13F valueReported value at the end of Q2 2026
$70.1M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in GBP.

Revenue, FY2025
GBP 32.7B
+4.1% year over year
Net income, FY2025
GBP 6.29B
+113.1% year over year
Free cash flow, FY2025
GBP 6.39B
+24.0% year over year

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
1.25M
Shares sold short
Change
+44.6K
+3.7% vs. previous
Days to cover
> 999
Above FINRA's cap of 999.99 days

Superinvestors holding GLAXF, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GLAXF at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by GSK plc insiders from Form 4, newest first.

No open-market purchases or sales by GSK plc insiders are on file.

Top 10 13F holders, Q2 2026

See all 2 holders

The largest institutional positions in GSK plc at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding GLAXF in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Aristotle Capital Management, LLC2,633,914$69.3M0.15%−190,807−6.8%Reduced
Generali Investments CEE, investicni spolecnost, a.s.34,105$895.8K0.04%−4,209−11.0%Reduced

Holders of 5% or more of GLAXF

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of GSK plc.

Largest holders of GLAXF from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A8.90%369.6M shares–Mar 7, 20251 filingMar 7, 2025SEC
FMR LLC13G5.80%234.9M sharesNewMay 6, 20261 filingMay 6, 2026SEC

12 members of Congress reported 45 trades in GSK plc since 2020. Newest filings:

  1. Alan Armstrong

    Senate · OK · Jul 21, 2026

    Buy$15K-$50K

  2. Lisa C. McClain

    House · MI · Nov 21, 2025

    Sell$1K-$15K

  3. Lisa C. McClain

    House · MI · Nov 21, 2025

    Buy$1K-$15K

  4. Lisa C. McClain

    House · MI · Nov 21, 2025

    Sell$1K-$15K

  5. Val T. Hoyle

    House · OR · Oct 10, 2025

    Sell$1K-$15K